FBTAX vs. IBB
Compare and contrast key facts about Fidelity Advisor Biotechnology Fund Class A (FBTAX) and iShares Nasdaq Biotechnology ETF (IBB).
FBTAX is managed by Fidelity. It was launched on Dec 27, 2000. IBB is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology Index. It was launched on Feb 5, 2001.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FBTAX or IBB.
Correlation
The correlation between FBTAX and IBB is 0.94, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
FBTAX vs. IBB - Performance Comparison
Key characteristics
FBTAX:
-0.29
IBB:
-0.21
FBTAX:
-0.27
IBB:
-0.17
FBTAX:
0.97
IBB:
0.98
FBTAX:
-0.21
IBB:
-0.13
FBTAX:
-0.77
IBB:
-0.72
FBTAX:
7.57%
IBB:
5.05%
FBTAX:
19.79%
IBB:
17.38%
FBTAX:
-60.08%
IBB:
-62.85%
FBTAX:
-27.15%
IBB:
-24.60%
Returns By Period
In the year-to-date period, FBTAX achieves a -4.56% return, which is significantly lower than IBB's -0.48% return. Over the past 10 years, FBTAX has underperformed IBB with an annualized return of 1.03%, while IBB has yielded a comparatively higher 2.42% annualized return.
FBTAX
-4.56%
-9.55%
-17.75%
-6.05%
-0.87%
1.03%
IBB
-0.48%
-3.65%
-10.90%
-3.79%
1.74%
2.42%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBTAX vs. IBB - Expense Ratio Comparison
FBTAX has a 1.00% expense ratio, which is higher than IBB's 0.47% expense ratio.
Risk-Adjusted Performance
FBTAX vs. IBB — Risk-Adjusted Performance Rank
FBTAX
IBB
FBTAX vs. IBB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class A (FBTAX) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FBTAX vs. IBB - Dividend Comparison
FBTAX's dividend yield for the trailing twelve months is around 3.06%, more than IBB's 0.29% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBTAX Fidelity Advisor Biotechnology Fund Class A | 3.06% | 2.92% | 1.15% | 0.00% | 0.79% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 5.36% | 2.45% |
IBB iShares Nasdaq Biotechnology ETF | 0.29% | 0.29% | 0.26% | 0.31% | 0.21% | 0.20% | 0.17% | 0.19% | 0.30% | 0.19% | 0.03% | 0.15% |
Drawdowns
FBTAX vs. IBB - Drawdown Comparison
The maximum FBTAX drawdown since its inception was -60.08%, roughly equal to the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for FBTAX and IBB. For additional features, visit the drawdowns tool.
Volatility
FBTAX vs. IBB - Volatility Comparison
Fidelity Advisor Biotechnology Fund Class A (FBTAX) has a higher volatility of 7.97% compared to iShares Nasdaq Biotechnology ETF (IBB) at 5.83%. This indicates that FBTAX's price experiences larger fluctuations and is considered to be riskier than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.